NCT00366522View on ClinicalTrials.gov

Study Evaluating LXR-623 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Healthy

Interventions

DRUG

LXR-623

Trial Locations (1)

68502

Lincoln

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00366522 - Study Evaluating LXR-623 in Healthy Subjects | Biotech Hunter | Biotech Hunter